4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-011298
Chief Financial Officer sold 318 shares at $10.22 ($3,250)
From the SEC's structured data for this filing
Trades in this filing
Trigilio Jeffrey · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-12 | Sale : show line 1 in the form | −318 | $10.22 | $3,250 | 87,685 | D |
| Open-market sales · 318 sh · avg $10.22 · $3,250 | ||||||
Loading xslF345X04/doc4.xml…